Markers and Immunoprofile of Extraskeletal Osseous and Cartilaginous Tumors

, Hans Guski2 and Glen Kristiansen3



(1)
Carl-Thiem-Klinikum, Institut für Pathologie, Cottbus, Germany

(2)
Vivantes Klinikum Neukölln, Institut für Pathologie, Berlin, Germany

(3)
Universität Bonn, UKB, Institut für Pathologie, Bonn, Germany

 




Diagnostic Antibody Panel for Osseous and Cartilaginous Tumors

S100, osteocalcin, osteonectin, androgen receptors, SATB-2, pan-cytokeratin [1, 2].


Osteocalcin:

Osteocalcin is a non-collagenous calcium-binding protein synthesized by osteoblasts involved in the mineralization of bone tissue and dentin. It is expressed by osteoblasts in the bone and dentin. Osteocalcin is a specific marker for bone and osteogenic tumors.
























Osteonectin

Expression pattern: cytoplasmic

Main diagnostic use

Expression in other tumors

Expression in normal cells

Bone tumors

Sarcomatoid renal cell carcinoma, cartilaginous tumors

Osteocytes, fibroblasts, endothelium, subset of epithelial cells

Positive control: bone tissue


Diagnostic Approach

Osteonectin is a calcium-binding bone matrix glycoprotein involved in the early mineralization steps of bone tissue. It is highly expressed in activated osteocytes. It is also expressed to a lesser degree in other cell types such as fibroblasts, endothelial cells, chondrocytes, and some epithelial types; consequently, osteonectin has a high sensitivity but low specificity for bone tissue and bone tumors and must be a part of antibody panel.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Dec 25, 2017 | Posted by in ONCOLOGY | Comments Off on Markers and Immunoprofile of Extraskeletal Osseous and Cartilaginous Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access